Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003356priorityCriticalpatent/ECSP003356A/en
Publication of ECSP003356ApublicationCriticalpatent/ECSP003356A/en
Agricultural Chemicals And Associated Chemicals
(AREA)
Abstract
La invención se refiere a epotilonas en las cuales el substituyente tiazol se ha modificado, con métodos para su preparación y con agentes funguicidas o terapéuticos que contienen estas epotilonas.The invention relates to epothilones in which the thiazole substituent has been modified, with methods for its preparation and with fungicidal or therapeutic agents that contain these epothilones.
A PHARMACEUTICAL COMPOSITION THAT INCLUDES POLYMODIC FORMS OF 3- (4-AMINO-1-OXO-1.3 DYHIDRO-ISOINDOL-2-IL) -PIPERIDINA-2,6-DIONA FOR THE TREATMENT AND HANDLING OF CANCERES
NITROGEN HETEROCICLIC COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND TO TREAT OR PREVENT A CONDITION THROUGH P38, WHICH CONSISTS OF AN INFLAMMATORY, AUTO-IMMUNE, VIROSICAL OR NEURODEGENERATIVE DISEASE.